Malignant conjunctival melanoma - Clinical review with recommendations for diagnosis, therapy and follow-up;Das maligne melanom der bindehaut - Klinische übersicht mit empfehlungen zur diagnose, therapie und nachsorge

Klinische Monatsblatter fur Augenheilkunde

Volumn 219, Issue 10, 2002, Pages 710-721

  Lommatzsch, Peter K ^a   Werschnik, Cornelia ^b  

^a Augenarztliche Gemeinschaftspraxis   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Conjunctival melanoma; Diagnosis; Epidemiology; Prognosis; Risc factors; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

BRAIN FORNIX; CANCER CELL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONJUNCTIVA TUMOR; CRYOTHERAPY; EXCISION; HUMAN; LOCAL THERAPY; MELANOMA; METASTASIS; PROGNOSIS; RECURRENCE RISK; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT FAILURE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; VISION;

COMBINED MODALITY THERAPY; CONJUNCTIVA; CONJUNCTIVAL NEOPLASMS; HUMANS; MELANOMA; NEOPLASM STAGING; PROGNOSIS;

EID: 0036815079     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35693     Document Type: Review

References (45)

1. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: A retrospective study. Br J Ophthalmol 2002; 86: 163-167
2. Aoyagi M, Morishima N, Yoshino J, Imagawa N, Kiyosawa M, Ito M et al. Conjunctival malignant melanoma with xeroderma pigmentosum. Ophthalmologica 1993; 206: 162-167
3. Arocker-Mettinger E, Haddad R. Zur berhandlung der primär erworbenen melanose der bindehaut. Klin Mbl Augenheilk 1985; 187: 353-355
4. Chau KY, Hui SP, Cheng GP. Conjunctival melanotic lesions in Chinese: Comparison with Caucasian series. Pathology 1999; 31: 199-201
5. Crawford JB. Conjunctival tumors. In: Tasman W (ed): Duane's Ophthalmology. Philadelphia: Lippencott Raven, 1998
6. De Potter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: A review of 68 cases. Br J Ophthalmol 1993; 77: 624-630
7. De Wolff-Rouendaal D. Conjunctival Melanoma in the Netherlands: A Clinico-Pathological and Follow-up Study. Proefschrift van de graad van Doctor aan de Rijksuniversiteit te Leiden. Den Haag: CIP-gegevens Koninklijke Bibliotheek, 1990, ISBN 90-9003351-3
8. De Wolff-Rouendaal D. Melanozytäre tumoren der bindehaut. In: Lommatzsch PK (ed): Ophthalmologische Onkologie. Stuttgart: Enke, 1999: 81-95
9. El-Shabrawi Y, Radner H, Muellner K, Langmann G, Hoefler G. The role of UV radiation in the development of conjunctival malignant melanoma. Acta Ophthalmol Scand 1999; 77: 31-32
10. Esmaeli B, Eicher S, Popp J, Delpassand E, Prieto VG, Gershenwald E. Sentinel lymphnode biopsy for conjunctival melanoma. Ophthalmic Plastic and Reconstructive Surgery 2001; 17: 436-442
11. Folberg R, McLean IW, Zimmerman LE. Malignant melanoma of the conjunctiva. Hum Pathol 1985; 16: 136-143
12. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984; 91: 673-678
13. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985a; 16: 129-135
14. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva. Terminology, classification and biological behaviour. Hum Pathol 1986; 17: 652-654
15. Folberg R, Baron J, Reeves RD et al. Animal model of conjunctival primary acquired melanosis. Ophthalmology 1989; 96: 1006-1013
16. Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Bening conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology 1989; 96: 436-461
17. Foss AJ, Alexander RA, Guille MJ, Hungerford JL, McCartney AC, Lightman S. Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology 1995; 102: 431-435
18. Frucht-Pery J, Péer J. Use of mitomycin in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996; 114: 1261-1264
19. Gebhardt H. Inzidenz von Lid- und Aderhautmelanom in der DDR im Zeitraum 1968-1980. Dissertation zur Promotion A. Leipzig: Karl-Marx-Universität, 1985
20. Graham BJ, Duane TD. Ocular melanoma task force report. Am J Ophthalmol 1980; 90: 728-733
21. Henkind P. Conjunctival melanocytic lesions. Natural history. In: Jakobiec FA (ed): Ocular and Adnexal Tumors. Birmingham, Alabama: Aesculapius Publishing Company, 1978: 572-582
22. Jakobiec FA, Rini FJ, Fraunfelder FT, Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology 1988; 95: 1058-1070
23. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989; 96: 147-166
24. Layton C, Glasson W. Clinical aspects of conjunctival melanoma. Clinical and Experimental Ophthalmology 2002; 30: 72-79
25. Lederman M. Radiotherapy of malignant melanomata of the eye. Br J Radiol 1961; 34: 21-42
26. Lommatzsch PK. Beta irradiation of conjunctival melanomas. Trans Ophthal Soc UK 1977; 97: 378-380
27. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990; 74: 615-619
28. Lommatzsch PK. Beta-ray treatment of malignant epibulbar melanoma. Graefes Arch Klin Exp Ophthalmol 1978; 209: 111-124
29. Lommatzsch PK, Werschnik C, Gütz U. Intraokulare ausbreitung eines melanoms der bindehaut. Klin Monatsbl Augenheilk 1999; 215: 370-372
30. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva. Occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234: 569-572
31. Notter G. Das maligne epibulbäre melanom. Strahlentherapie 1955; 96: 518-537
32. Paridaens ADA, Minassian DC, McCartney ACE, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: A clinicopathological study of 256 cases. Br J Ophthalmol 1994; 78: 252-259
33. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-1991. Acta Ophthalmol (Copenh) 1992; 70: 289-296
34. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998; 42: 321-350
35. Shields CL, Shields JA, Gündüz K, Cater J, Mercado GV, Gross N, Lally B. Risk factors for recurrence, exenteration, metastases, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497-1507
36. Shields CL. Conjunctival melanoma: risk factors for recurrence, exenteration, metastases, and death in 150 consecutive patients. Tr Am Ophth Soc Vol 2000; 98: 471-491
37. Shields JA, Shields CL, de Potter P. Surgical management of circumscribed conjunctival melanomas. Ophthalmic Plast Reconstr Surg 1998; 14: 208-215
38. Shields CL, Shields JA, Armstrong T. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am J Ophthalmol 2001; 132: 576-578
39. Shields CL. Conjunctival melanoma. Clinical and histopathological prognostic parameters. Br J Ophthalmol 2002; 86: 127
40. Stefani FH. Das maligne melanom der bindehaut - Klinischer verlauf und histopathologischer befund. Fortschr Ophthalmol 1986; 83: 141-145
41. Tuomaala S, Aine E, Saari KM, Kivelä T. Corneally displaced malignant conjunctival melanomas. Ophthalmology 2002; 109: 914-919
42. Wenkel H, Rummelt V, Naumann GOH. Malignant melanoma of the conjunctiva with intraocular extension. Arch Ophthalmol 2000; 118: 557-560
43. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002; 25 (3): 248-255
44. Werschnik C, Lommatzsch PK. Mitomycin C bei der behandlung von bindehautmelanomen und primär erworbenen melanosen. Klin Monatsbl Augenheilk 1998; 212: 465-468
45. Zehetmayer M, Menapace R, Kulnig W. Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies. Ophthalmologica 1993; 207: 615-619